2008
DOI: 10.1182/blood-2008-07-165795
|View full text |Cite
|
Sign up to set email alerts
|

Raising the spectra of T-cell profiling

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2013
2013
2014
2014

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(3 citation statements)
references
References 7 publications
(3 reference statements)
0
3
0
Order By: Relevance
“…A required normalization parameter for this model is the radio flux at 1 GHz. We use a value of 1.24 Jy, which has been derived by starting with the value from Reynolds et al (2009), 1.17 GHz, and accounting for for the observed increase of the radio flux of roughly 1.2% per year (Murphy et al 2008). Figure 5 shows that the srcut model gives an excellent fit (reduced χ 2 of 1.06) over the whole energy band from 0.5 to 30 keV.…”
Section: Discussionmentioning
confidence: 99%
“…A required normalization parameter for this model is the radio flux at 1 GHz. We use a value of 1.24 Jy, which has been derived by starting with the value from Reynolds et al (2009), 1.17 GHz, and accounting for for the observed increase of the radio flux of roughly 1.2% per year (Murphy et al 2008). Figure 5 shows that the srcut model gives an excellent fit (reduced χ 2 of 1.06) over the whole energy band from 0.5 to 30 keV.…”
Section: Discussionmentioning
confidence: 99%
“…There has been much historical interest in these factors, and although efforts have been made to profile patient T-cell repertoires after HSCT using spectratyping, they have always yielded an incomplete view [33]. Now, using TCR-seq, investigators can examine more comprehensively the repertoires of HSCT patients, yielding much more incisive and reliable insights into post-HSCT repertoire reconstitution.…”
Section: New Insights From T-cell Repertoire Analysis By Tcr-seqmentioning
confidence: 99%
“…Numerous T-cell repertoire considerations are relevant to this procedure, including: (i) the source of the HSCs - bone marrow, peripheral blood or umbilical cord, autologous or allogeneic; (ii) the risk for, incidence of, and potential methods for mitigation and treatment of ‘graft versus host disease’ (GVHD) post-transplant (wherein donor T cells are reactive against host antigens); (iii) the prevention and treatment of post-transplant infection and malignancy resulting from lymphopenia and immunosuppression; and (iv) the timescale and nature of the post-transplant reconstitution of the TCR repertoire. There has been much historical interest in these factors, and although efforts have been made to profile patient T-cell repertoires after HSCT using spectratyping, they have always yielded an incomplete view [ 33 ]. Now, using TCR-seq, investigators can examine more comprehensively the repertoires of HSCT patients, yielding much more incisive and reliable insights into post-HSCT repertoire reconstitution.…”
Section: New Insights From T-cell Repertoire Analysis By Tcr-seqmentioning
confidence: 99%